Prestige Biologics Co., Ltd. (KOSDAQ:334970)
South Korea · Delayed Price · Currency is KRW 1,907.00
+18.00 (0.95%)
At close: Jun 12, 2026
Prestige Biologics Market Cap
Prestige Biologics has a market cap or net worth of 148.27 billion as of June 12, 2026. Its market cap has decreased by -51.14% in one year.
Market Cap
148.27B
Enterprise Value
232.70B
Revenue
18.03B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,907.00
Market Cap Chart
Since March 11, 2021, Prestige Biologics's market cap has decreased from 613.27B to 148.27B, a decrease of -75.82%. That is a compound annual growth rate of -23.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 148.27B | -37.17% |
| Dec 30, 2025 | 235.98B | -40.12% |
| Dec 30, 2024 | 394.06B | 46.25% |
| Dec 28, 2023 | 269.45B | 46.01% |
| Dec 29, 2022 | 184.55B | -59.28% |
| Dec 30, 2021 | 453.18B | -26.10% |
| Mar 11, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NIBEC | 212.69B |
| Y-Biologics | 205.66B |
| ViGenCell | 190.03B |
| Bio Solution | 183.21B |
| Ensol Biosciences | 170.41B |
| TiumBio | 155.30B |
| ISU Abxis | 131.70B |
| CORESTEMCHEMON | 112.23B |